Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers-Reference-Cited by-同舟云学术

Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers

Published:2015-03 Issue: Volume:70 Page:190-195
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Bayoglu Ibrahim Vedat,Kucukzeybek Betul Bolat,Kucukzeybek Yuksel,Varol Umut,Yildiz Ibrahim,Alacacioglu Ahmet,Akyol Murat,Demir Lutfiye,Dirican Ahmet,Yildiz Yasar,Salman Tarik,Tarhan Mustafa Oktay

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference35 articles.

1. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers;Chang;Proc Natl Acad Sci U S A,1996

2. Isolation and characterization of a monoclonal antibody K1, reactive with ovarian cancers and normal mesothelium;Chang;Int J Cancer,1992

3. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE);Argani;Clin Cancer Res,2001

4. Value of mesothelin immunostaining in the diagnosis of mesothelioma;Ordonez;Mod Pathol,2003

5. Application of mesothelin immunostaining in tumor diagnosis;Ordonez;Am J Surg Pathol,2003

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biology of Mesothelin and Clinical Implications: A Review of Existing Literature;World Journal of Oncology;2023-10

2. Mesothelin-targeted CAR-NK Cells Derived From Induced Pluripotent Stem Cells Have a High Efficacy in Killing Triple-negative Breast Cancer Cells as Shown in Several Preclinical Models;Journal of Immunotherapy;2023-08-15

3. Advances in chimeric antigen receptor T cells therapy in the treatment of breast cancer;Biomedicine & Pharmacotherapy;2023-06

4. Targeting Mesothelin in Solid Tumours: Anti-mesothelin Antibody and Drug Conjugates;Current Oncology Reports;2023-02-10

5. Mesothelin‑specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3‑treated self‑differentiated dendritic cells;Oncology Reports;2022-05-25